270 related articles for article (PubMed ID: 16281934)
1. The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure.
Beesley AH; Cummings AJ; Freitas JR; Hoffmann K; Firth MJ; Ford J; de Klerk NH; Kees UR
Br J Haematol; 2005 Nov; 131(4):447-56. PubMed ID: 16281934
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel molecular prognostic markers for paediatric T-cell acute lymphoblastic leukaemia.
Gottardo NG; Hoffmann K; Beesley AH; Freitas JR; Firth MJ; Perera KU; de Klerk NH; Baker DL; Kees UR
Br J Haematol; 2007 May; 137(4):319-28. PubMed ID: 17456054
[TBL] [Abstract][Full Text] [Related]
3. Prediction of relapse in paediatric pre-B acute lymphoblastic leukaemia using a three-gene risk index.
Hoffmann K; Firth MJ; Beesley AH; Freitas JR; Ford J; Senanayake S; de Klerk NH; Baker DL; Kees UR
Br J Haematol; 2008 Mar; 140(6):656-64. PubMed ID: 18302714
[TBL] [Abstract][Full Text] [Related]
4. Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemia.
Kirschner-Schwabe R; Lottaz C; Tödling J; Rhein P; Karawajew L; Eckert C; von Stackelberg A; Ungethüm U; Kostka D; Kulozik AE; Ludwig WD; Henze G; Spang R; Hagemeier C; Seeger K
Clin Cancer Res; 2006 Aug; 12(15):4553-61. PubMed ID: 16899601
[TBL] [Abstract][Full Text] [Related]
5. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
6. Validation by RQ-PCR and flow cytometry of alpha-defensin1-3 (DEFA1-3) overexpression in relapsed and refractory acute lymphoblastic leukemia.
Te Kronnie G; Bicciato S; Franceschini L; Accordi B; Dellíorto MC; Rinaldi A; Pession A; Barisone E; Conter V; Locatelli F; Basso G
Oncol Rep; 2006 Feb; 15(2):341-6. PubMed ID: 16391852
[TBL] [Abstract][Full Text] [Related]
7. Relapse of acute lymphoblastic leukemia in children in the context of microarray analyses.
Szczepanek J; Styczyński J; Haus O; Tretyn A; Wysocki M
Arch Immunol Ther Exp (Warsz); 2011 Feb; 59(1):61-8. PubMed ID: 21246408
[TBL] [Abstract][Full Text] [Related]
8. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia.
Kaspers GJ; Wijnands JJ; Hartmann R; Huismans L; Loonen AH; Stackelberg A; Henze G; Pieters R; Hählen K; Van Wering ER; Veerman AJ
Eur J Cancer; 2005 Jun; 41(9):1300-3. PubMed ID: 15869873
[TBL] [Abstract][Full Text] [Related]
10. Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence.
Wu S; Gessner R; von Stackelberg A; Kirchner R; Henze G; Seeger K
Cancer; 2005 Mar; 103(5):1054-63. PubMed ID: 15651075
[TBL] [Abstract][Full Text] [Related]
11. CD22 Exon 12 deletion is a characteristic genetic defect of therapy-refractory clones in paediatric acute lymphoblastic leukaemia.
Ma H; Qazi S; Ozer Z; Gaynon P; Reaman GH; Uckun FM
Br J Haematol; 2012 Jan; 156(1):89-98. PubMed ID: 22017452
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of multidrug resistance gene (MDR1) at relapse in a child with acute lymphoblastic leukemia.
Kourti M; Vavatsi N; Gombakis N; Tzimagiorgis G; Sidi V; Koliouskas D; Athanassiadou F
Pediatr Hematol Oncol; 2006 Sep; 23(6):489-94. PubMed ID: 16849280
[TBL] [Abstract][Full Text] [Related]
13. Expression of angiogenic factors in childhood B-cell precursor acute lymphoblastic leukemia.
Stachel D; Albert M; Meilbeck R; Paulides M; Schmid I
Oncol Rep; 2007 Jan; 17(1):147-52. PubMed ID: 17143492
[TBL] [Abstract][Full Text] [Related]
14. Identification of prognosis markers in pediatric high-risk acute lymphoblastic leukemia.
Al-Lamki Z; Wali YA; Wasifuddin SM; Zachariah M; Al-Mjeni R; Li C; Muralitharan S; Al-Kharusi K; Gunaratne P; Peterson L; Gibbs R; Gingras MC; Margolin JF
Pediatr Hematol Oncol; 2005; 22(7):629-43. PubMed ID: 16166056
[TBL] [Abstract][Full Text] [Related]
15. Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens.
Kalina T; Vaskova M; Mejstrikova E; Madzo J; Trka J; Stary J; Hrusak O
BMC Cancer; 2005 Apr; 5():38. PubMed ID: 15826304
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
Raetz EA; Perkins SL; Bhojwani D; Smock K; Philip M; Carroll WL; Min DJ
Pediatr Blood Cancer; 2006 Aug; 47(2):130-40. PubMed ID: 16358311
[TBL] [Abstract][Full Text] [Related]
17. Tiling resolution array comparative genomic hybridization, expression and methylation analyses of dup(1q) in Burkitt lymphomas and pediatric high hyperdiploid acute lymphoblastic leukemias reveal clustered near-centromeric breakpoints and overexpression of genes in 1q22-32.3.
Davidsson J; Andersson A; Paulsson K; Heidenblad M; Isaksson M; Borg A; Heldrup J; Behrendtz M; Panagopoulos I; Fioretos T; Johansson B
Hum Mol Genet; 2007 Sep; 16(18):2215-25. PubMed ID: 17613536
[TBL] [Abstract][Full Text] [Related]
18. [Expression of MOST-1 mRNA in bone marrow mononuclear cells from patients with acute lymphoblastic leukemia].
Gao J; Yuan LX; Sun L; Li XX; Liao QK
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):638-40. PubMed ID: 15460406
[TBL] [Abstract][Full Text] [Related]
19. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of the reduced folate carrier, the major membrane transporter for methotrexate, in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Ge Y; Haska CL; LaFiura K; Devidas M; Linda SB; Liu M; Thomas R; Taub JW; Matherly LH
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):451-7. PubMed ID: 17255265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
